國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Gene therapy for HIV and chronic inf...

Berkhout, Ben.

Gene therapy for HIV and chronic infections

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Gene therapy for HIV and chronic infectionsedited by Ben Berkhout, Hildegund C.J. Ertl, Marc S. Weinberg.
其他作者:	Ertl, Hildegund C.J.
出版者:	New York, NY :Springer New York :2015.
面頁冊數:	xvi, 236 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	HIV infectionsGene therapy.
電子資源:	http://dx.doi.org/10.1007/978-1-4939-2432-5
ISBN:	9781493924325 (electronic bk.)

Gene therapy for HIV and chronic infections
Gene therapy for HIV and chronic infections[electronic resource] /edited by Ben Berkhout, Hildegund C.J. Ertl, Marc S. Weinberg. - New York, NY :Springer New York :2015. - xvi, 236 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.8480065-2598 ;. - Advances in experimental medicine and biology ;946..

Gene Therapies for Hepatitis C Virus -- Recent Advances in Use of Gene Therapy to Treat Hepatitis B Virus Infection -- U1interference (U1i) for antiviral approaches -- Gene therapy strategies to block HIV-1 replication by RNA interference -- HIV and Ribozymes -- Editing CCR5: a novel approach to HIV gene therapy -- Synthetic DNA approach to Cytomegalovirus vaccine/immune therapy -- Vector-mediated antibody gene transfer for infectious diseases -- HIV latency and the non-coding RNA therapeutic landscape -- C peptides as entry inhibitors for gene therapy -- Aptamer-siRNA chimeras for HIV.

This volume examines gene therapy and gene transfer approaches to preventing or treating chronic virus infections, focusing on the Big Three viral pathogens- HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) It explores molecular antiviral strategies, including RNA interference, aptamer-siRNA chimeras, U1i interference, editing CCR5, alternative genetic vaccination by intramuscular gene transfers of virus vectors, and HIV latency in the context of non-coding RNA. This title is a volume of the American Society of Gene and Cell Therapy, a sub-series of the highly successful advances in experimental medicine and biology. In eleven illustrated chapters, leading international researchers contextualize the structure, operation, and impact of pathogens; examine the existing genetic and molecular research; and extract possible methods of preventing and treating chronic viral infections while evaluating the current body of knowledge. Authoritative and multifaceted, Gene Therapy for HIV and Chronic Infections is an ideal guide for researchers in the fields of gene therapy and immunology interested in expanding their knowledge on how to design an effective gene therapy against a viral pathogen.

ISBN: 9781493924325 (electronic bk.)

Standard No.: 10.1007/978-1-4939-2432-5doiSubjects--Topical Terms:

678817
HIV infections
--Gene therapy.

LC Class. No.: RC606.6

Dewey Class. No.: 616.979206

Gene therapy for HIV and chronic infections
LDR:02866nmm a2200325 a 4500 001 462407
003 DE-He213
005 20151006142911.0
006 m d
007 cr nn 008maaau
008 151119s2015 nyu s 0 eng d
020 $a 9781493924325 (electronic bk.)
020 $a 9781493924318 (paper)
024 7 $a 10.1007/978-1-4939-2432-5 $2 doi
035 $a 978-1-4939-2432-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC606.6
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 616.979206 $2 23
090 $a RC606.6 $b .G326 2015
245 0 0 $a Gene therapy for HIV and chronic infections $h [electronic resource] / $c edited by Ben Berkhout, Hildegund C.J. Ertl, Marc S. Weinberg.
260 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2015.
300 $a xvi, 236 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.848
505 0 $a Gene Therapies for Hepatitis C Virus -- Recent Advances in Use of Gene Therapy to Treat Hepatitis B Virus Infection -- U1interference (U1i) for antiviral approaches -- Gene therapy strategies to block HIV-1 replication by RNA interference -- HIV and Ribozymes -- Editing CCR5: a novel approach to HIV gene therapy -- Synthetic DNA approach to Cytomegalovirus vaccine/immune therapy -- Vector-mediated antibody gene transfer for infectious diseases -- HIV latency and the non-coding RNA therapeutic landscape -- C peptides as entry inhibitors for gene therapy -- Aptamer-siRNA chimeras for HIV.
520 $a This volume examines gene therapy and gene transfer approaches to preventing or treating chronic virus infections, focusing on the Big Three viral pathogens- HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) It explores molecular antiviral strategies, including RNA interference, aptamer-siRNA chimeras, U1i interference, editing CCR5, alternative genetic vaccination by intramuscular gene transfers of virus vectors, and HIV latency in the context of non-coding RNA. This title is a volume of the American Society of Gene and Cell Therapy, a sub-series of the highly successful advances in experimental medicine and biology. In eleven illustrated chapters, leading international researchers contextualize the structure, operation, and impact of pathogens; examine the existing genetic and molecular research; and extract possible methods of preventing and treating chronic viral infections while evaluating the current body of knowledge. Authoritative and multifaceted, Gene Therapy for HIV and Chronic Infections is an ideal guide for researchers in the fields of gene therapy and immunology interested in expanding their knowledge on how to design an effective gene therapy against a viral pathogen.
650 0 $a HIV infections $x Gene therapy. $3 678817
650 0 $a HIV infections $x Treatment. $3 318169
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Gene Therapy. $3 196467
650 2 4 $a Immunology. $3 189152
650 2 4 $a Biomedicine general. $3 273948
700 1 $a Ertl, Hildegund C.J. $3 715358
700 1 $a Weinberg, Marc S. $3 715359
700 1 $a Berkhout, Ben. $3 715357
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-1-4939-2432-5
950 $a Biomedical and Life Sciences (Springer-11642)